Where music, human connection, and rigorous inquiry meet. Explore the people, practices, and evidence shaping music therapy.
A guitar, a voice, a rhythm: the encounter is personal. The evidence must be precise. This alternative visual language gives music and people a stronger stage while keeping clinical claims grounded in study design, outcome, and applicability.
Music is deeply human. Its therapeutic claims deserve deeply careful evidence.
Each area has a different kind of evidence. Clinical treatment, structured listening, and general wellness music require different claims and safeguards.
Depression, anxiety, grief, emotional regulation, relaxation, and sleep. Clinical depression findings concern therapist-led care added to usual treatment; sleep findings often concern recorded listening.
Rhythm can supply timing cues for movement. Music also engages attention, memory, and emotional processing, but a brain response alone does not prove clinical benefit.
Qualified therapists use individualized musical interaction toward defined goals in rehabilitation, mental health, oncology, dementia care, and other settings. Outcomes vary by condition and measure.
Tempo, rhythm, musical preference, cultural familiarity, and listening context can guide music designed for a specific experience. A composition becomes a clinical intervention only when its use and outcomes are properly evaluated.
Adaptive composition and preference-based playlists are research opportunities. To establish benefit, compare them with ordinary preference-matched listening on predefined outcomes and monitor adverse responses.
Develop listening experiences, services, or digital products with clear claims, accessible design, and appropriate clinical oversight. Match every benefit statement to the population and intervention actually studied.
Illustrations are conceptual and do not depict study participants or documented clinical outcomes.
A curated first-pass extraction of the studies discussed in this project. “Not extracted” means a comparable numerical estimate still needs verification from the full text. Individual-trial bias notes are screening flags, not formal RoB 2 ratings.
| Study and design | Population / sample | Intervention → comparator | Outcomes and effect estimate | Bias / applicability |
|---|
Reviews can include trials shown separately here. Their participant totals must not be added together. Estimates apply to specified outcomes and comparators.
Primary studies, evidence syntheses, and professional research agendas serve different purposes. Follow each link to inspect methods and full results.
A positive result in one population or on one scale does not establish a universal therapeutic effect.
This atlas is a starting point. The next research layer will extract design, sample, intervention, comparator, outcomes, effect estimates, risk of bias, and applicability in a consistent format for every study.
Browse the current matrix ↗